Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breastfeeding-related maternal microchimerism.
Molès JP, Tuaillon E, Kankasa C, Bedin AS, Nagot N, Marchant A, McDermid JM, Van de Perre P. Molès JP, et al. Among authors: kankasa c. Nat Rev Immunol. 2017 Nov;17(11):729-1. doi: 10.1038/nri.2017.115. Epub 2017 Oct 3. Nat Rev Immunol. 2017. PMID: 28972205 No abstract available.
Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174.
Nagot N, Kankasa C, Meda N, Hofmeyr J, Nikodem C, Tumwine JK, Karamagi C, Sommerfelt H, Neveu D, Tylleskär T, Van de Perre P; PROMISE-PEP group. Nagot N, et al. Among authors: kankasa c. BMC Infect Dis. 2012 Oct 6;12:246. doi: 10.1186/1471-2334-12-246. BMC Infect Dis. 2012. PMID: 23039034 Free PMC article. Clinical Trial.
Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Maréchal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskär T, Van de Perre P; ANRS 12174 Trial Group. Nagot N, et al. Among authors: kankasa c. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Lancet. 2016. PMID: 26603917 Clinical Trial.
Increased Epstein-Barr virus in breast milk occurs with subclinical mastitis and HIV shedding.
Sanosyan A, Rutagwera DG, Molès JP, Bollore K, Peries M, Kankasa C, Mwiya M, Tylleskär T, Nagot N, Van De Perre P, Tuaillon E; ANRS 12174 Trial Group (see composition at the Acknowledgments Section). Sanosyan A, et al. Among authors: kankasa c. Medicine (Baltimore). 2016 Jul;95(27):e4005. doi: 10.1097/MD.0000000000004005. Medicine (Baltimore). 2016. PMID: 27399077 Free PMC article. Clinical Trial.
Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding.
Foissac F, Blume J, Tréluyer JM, Tylleskär T, Kankasa C, Meda N, Tumwine JK, Singata-Madliki M, Harper K, Illamola SM, Bouazza N, Nagot N, Van de Perre P, Blanche S, Hirt D. Foissac F, et al. Among authors: kankasa c. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01869-16. doi: 10.1128/AAC.01869-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27895016 Free PMC article.
Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial.
Somé EN, Engebretsen IMS, Nagot N, Meda N, Lombard C, Vallo R, Peries M, Kankasa C, Tumwine JK, Hofmeyr GJ, Singata M, Harper K, Van De Perre P, Tylleskar T; ANRS 12174 Trial Group. Somé EN, et al. Among authors: kankasa c. Int Breastfeed J. 2017 May 2;12:22. doi: 10.1186/s13006-017-0112-2. eCollection 2016. Int Breastfeed J. 2017. PMID: 28469697 Free PMC article.
Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial).
Somé EN, Engebretsen IMS, Nagot N, Meda NY, Vallo R, Kankasa C, Tumwine JK, Singata M, Hofmeyr JG, Van de Perre P, Tylleskär T; ANRs 12174 Trial Group. Somé EN, et al. Among authors: kankasa c. PLoS One. 2017 May 9;12(5):e0177259. doi: 10.1371/journal.pone.0177259. eCollection 2017. PLoS One. 2017. PMID: 28486519 Free PMC article. Clinical Trial.
159 results